The Latest Breaking News from Wegovy

GLP-1 Drugs Now Start as Low as $149 — But There’s a Catch

For Americans who have been priced out of popular weight-loss medications, a $149 monthly price tag sounds like welcome news. After years of seeing drugs...

Saving Advice · Oct 14

Liver Fat Fell to Normal in 23 of 26 Adults with Obesity in Small Wegovy Post Hoc Analysis

In a small Novo Nordisk analysis, 23 of 26 adults with obesity and excess liver fat reached normal levels on semaglutide. Here is what the numbers do and do not show.

Medical Daily · Oct 3

Novo Nordisk Increasingly Calls Wegovy Users Customers, Months After FDA Flagged a 'Live Lighter' Pill Ad Claim

STAT reports Novo now markets Wegovy to customers, months after the FDA called a Wegovy pill ad misleading. What cash-pay buyers should check first.

Medical Daily · Sep 30

Everything you need to know about the new Wegovy pill – and whether you should take it or not

LET’S UNPACK THAT: With massive demand for the GLP-1 tablets as they are approved for use in the UK, Helen Coffey asks experts how they differ from the jab and whether they are the next big step in the weight-loss revolution

The Independent UK · Jun 16

Can Wegovy move the needle on NZ’s obesity crisis, or simply treat its symptoms?

Even before receiving public funding, Wegovy has drawn much media attention in New Zealand for the dramatic difference it can make for weight loss.

The Conversation · May 31

Novo Nordisk A/S Q1 Earnings Call Highlights

Novo Nordisk A/S (NYSE:NVO) said its first quarter of 2026 was marked by rapid uptake of its newly launched Wegovy pill in the U.S., continued expansion of its obesity franchise and a series of pipeline and regulatory milestones, even as adjusted sales declined because of lower realized prices. Chi

MarketBeat · May 13

Early data links Wegovy to risk of 'eye stroke' — here's what to know

A rare form of vision loss has been linked to certain GLP-1s, but more so to Wegovy than to other weight-loss drugs in this class. Should you worry?

LiveScience · Apr 29

Wegovy Tragedy: Woman in Pain with 'Black Tongue' and Lost Organ After Weight Loss Jabs

Sarah-Jayne Crawford's weight-loss journey with Wegovy turned tragic, leading to severe health issues and organ removal. She now warns others about the potential risks of such treatments.

International Business Times UK · Apr 16

Novo Nordisk Just Announced Wegovy Subscriptions. Does That Make NVO Stock a Buy?

Wegovy subscriptions may create interest, but there is a major threat looming for Novo Nordisk.

Barchart · Apr 2

‘Major turning point’ as weight loss drugs to be prescribed to more NHS patients

Wegovy can now be prescribed for weight loss or to help reduce the risk of major cardiovascular events

The Independent UK · Mar 31